ARCHIVES

Progress Measures “Adequate,” Committee Says; Suggestions Include New Death Measure

This article is from The Cancer Letter archive.

Vol. 14 No. 33 | August 12, 1988

Download PDF Visit The Full Archive

Related Articles

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

NCI-Approved Clinical Trials

July 28, 2006

Science Policy: All’s Well In Access to Trials, GAO Study Finds; NIH Disagrees

November 5, 1999

New AIDs System For Classification Increase By 1% Cases Reported

August 1, 1986

New Research Projects Proposed For Immunology

September 30, 1977

In Brief: NCI Claim “Major Finding” In Treatment Of Soft Tissue Sarcoma With Three Modalities; 93% Survival

October 9, 1981